Using Video Images to Improve Advance Care Planning in Patients With Cancer

Advanced Cancer Clinical Trial

Official title:

Using Video Images to Improve Advance Care Planning in Patients With Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00970125
• Other study ID #: 2008-P-002156/2
• Secondary ID: R21CA139121-01
• Status: Completed
• Phase: N/A
• First received: August 6, 2009
• Last updated: April 28, 2012
• Start date: August 2009
• Est. completion date: June 2011

Study information

• Verified date: April 2012
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.

Description:

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: June 2011
• Est. primary completion date: June 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

1. Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:

• All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR

• Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR

• Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.

• The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).

2. Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).

3. English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.

4. Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.

5. Able to provide informed consent.

6. Age greater than or equal to 21.

Exclusion Criteria:

1. MMSE < 25.

2. Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Advanced Cancer

Intervention

Behavioral:
• video
outline of the goals of care

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	end of life preference at time of interview		5 minutes after survey	No
Secondary	knowledge		5 minutes after survey	No
Secondary	decisional conflict		5 minutes after survey	No